In this study, i.t. co-stimulation with CD40L by using adenoviral transduced DC with CD40L-coding adenoviruses could synergistically improve the antitumoral effects of vaccination with DC transduced with murine AFP-coding adenoviruses in pre-established HCC in vivo. The gene discussed is AFP; the disease is hepatocellular carcinoma.